RxDoctor Payments Data

Tanya Rodriguez, PA

Physician Assistant · Mission, TXNPI 1043973332

Payments from drug & device makers

$390in general payments, 2019–2025

Across 12 payments — averaging $32.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Dexcom, Inc.$116
  • AstraZeneca$100
  • Lilly USA, LLC$73
  • Exact Sciences$33
  • Amgen$22
  • Biohaven Pharmaceutical Holding Company Ltd.$17
  • plus $30 from 2 others

What the payments were for

  • Food & beverage$390100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$390 in reported general payments places this provider in the 50th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Medicare billing

Part B allowed, 2024
$20,373
Medicare patients
40
Services billed
639

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide16$18,631
Diclofenac Sodium16$383
Fluticasone Propionate25$314
Pioglitazone Hcl13$231
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst18$226
Omeprazole13$213
Gabapentin19$203
Montelukast Sodium13$194
Metoprolol Succinate14$186
Metformin Hcl16$128
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav15$123
Rosuvastatin Calcium21$119
Atorvastatin Calcium21$101
Ibuprofen14$100
Donepezil Hcl12$98

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$15$18,63116 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in Mission

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →